Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dutch Bros Inc (Class A) | Travis Boersma | Director, Executive Chairman of Board, Ten Percent Owner | 10 Feb 2025 | 5,064,794 | 5,080,404 | - | 0 | Class A Common Stock | ||
| Dutch Bros Inc (Class A) | Travis Boersma | Director, Executive Chairman of Board, Ten Percent Owner | 10 Feb 2025 | 5,064,794 | 30,227,251 | - | - | Class A Common Units | ||
| Dutch Bros Inc (Class A) | Travis Boersma | Director, Executive Chairman of Board, Ten Percent Owner | 10 Feb 2025 | 3,185,206 | 3,195,023 | - | 0 | Class A Common Stock | ||
| Dutch Bros Inc (Class A) | Travis Boersma | Director, Executive Chairman of Board, Ten Percent Owner | 10 Feb 2025 | 3,185,206 | 19,009,661 | - | - | Class A Common Units | ||
| Sionna Therapeutics Inc | Peter A. Thompson | Director | 10 Feb 2025 | 3,154,959 | 3,154,959 | - | - | Common Stock | ||
| Sionna Therapeutics Inc | Bruce Booth | Director | 10 Feb 2025 | 2,886,293 | 2,886,293 | - | - | Common Stock | ||
| ImmunityBio Inc | Patrick Soon-Shiong | Director, See remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 2,812,500 | 2,812,500 | - | - | Stock Option (right to buy) | |
| ImmunityBio Inc | Richard Adcock | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 2,812,500 | 2,812,500 | - | - | Stock Option (right to buy) | |
| Sionna Therapeutics Inc | Peter A. Thompson | Director | 10 Feb 2025 | 2,560,951 | 0 | - | - | Series B convertible preferred stock | ||
| Sionna Therapeutics Inc | Peter A. Thompson | Director | 10 Feb 2025 | 2,048,760 | 0 | - | - | Series C convertible preferred stock | ||
| Sionna Therapeutics Inc | Bruce Booth | Director | 10 Feb 2025 | 1,806,317 | 0 | - | - | Series A convertible preferred stock | ||
| Eastside Distilling Inc | Nicholas Liuzza R. | CEO of Subsidiary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 1,372,549 | 4,617,647 | - | - | Series G Convertible Preferred Stock | |
| Lyell Immunopharma Inc | Lynn Seely | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 1,350,000 | 1,350,000 | - | - | Option (right to buy) | |
| Sionna Therapeutics Inc | Bruce Booth | Director | 10 Feb 2025 | 1,298,332 | 0 | - | - | Series B convertible preferred stock | ||
| Eastside Distilling Inc | Nicholas Liuzza R. | CEO of Subsidiary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 1,284,314 | 3,245,098 | - | - | Series G Convertible Preferred Stock | |
| Sionna Therapeutics Inc | Bruce Booth | Director | 10 Feb 2025 | 1,092,504 | 0 | - | - | Series C convertible preferred stock | ||
| Sionna Therapeutics Inc | Bruce Booth | Director | 10 Feb 2025 | 1,051,051 | 0 | - | - | Series Seed convertible preferred stock | ||
| ImmunityBio Inc | David C. Sachs | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 843,750 | 843,750 | - | - | Stock Option (right to buy) | |
| ImmunityBio Inc | Patrick Soon-Shiong | Director, See remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 822,368 | 822,368 | - | - | Restricted Stock Units | |
| ImmunityBio Inc | Richard Adcock | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 822,368 | 822,368 | - | - | Restricted Stock Units | |
| Sionna Therapeutics Inc | Bruce Booth | Director | 10 Feb 2025 | 747,727 | 747,727 | - | - | Common Stock | ||
| Eastside Distilling Inc | Nicholas Liuzza R. | CEO of Subsidiary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 686,275 | 2,308,824 | - | - | Warrants to Purchase Common Stock | |
| Eastside Distilling Inc | Nicholas Liuzza R. | CEO of Subsidiary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 642,157 | 1,622,549 | - | - | Warrants to Purchase Common Stock | |
| Sionna Therapeutics Inc | Peter A. Thompson | Director | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 10 Feb 2025 | 550,000 | 3,704,959 | - | 18 | 9,900,000 | Common Stock |
| Enterprise Products Partners L P - Unit | Randa Duncan Williams | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 475,000 | 475,000 | - | - | Phantom Units | |
| Lyell Immunopharma Inc | Gary Lee | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 450,000 | 450,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Charles Newton W. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 450,000 | 450,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Lang Matthew | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 450,000 | 450,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Stephen Hill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 450,000 | 450,000 | - | - | Option (right to buy) | |
| Dominari Holdings Inc | Christopher Franklin Devall | COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 351,851 | 410,702 (8%) | 7% | - | Common Stock | |
| Enterprise Products Partners L P - Unit | Richard H. Bachmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 340,000 | 340,000 | - | - | Phantom Units | |
| Lyell Immunopharma Inc | Seely Lynn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 337,500 | 537,500 | - | 0 | Common Stock | |
| Arcus Biosciences Inc | Richard Markus | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 305,328 | 305,328 | - | - | Stock Option (right to buy) | |
| TeraWulf Inc | Paul B. Prager | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Feb 2025 | 298,000 | 800,883 | - | - | Common stock, $0.001 par value per share | |
| Dominari Holdings Inc | Anthony Hayes | Director, CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Feb 2025 | 288,184 | 288,184 | - | - | Series A Warrants (right to buy) | |
| Dominari Holdings Inc | Anthony Hayes | Director, CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Feb 2025 | 288,184 | 288,184 | - | - | Series B Warrants (right to buy) | |
| Dominari Holdings Inc | Anthony Hayes | Director, CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Feb 2025 | 288,184 | 975,007 (20%) | 5% | - | Common Stock | |
| Dominari Holdings Inc | Kyle Michael Wool | Director, President, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Feb 2025 | 288,184 | 2,200,769 (45%) | 5% | - | Common Stock | |
| Dominari Holdings Inc | Kyle Michael Wool | Director, President, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Feb 2025 | 288,184 | 288,184 | - | - | Series A Warrants (right to buy) | |
| Dominari Holdings Inc | Kyle Michael Wool | Director, President, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Feb 2025 | 288,184 | 288,184 | - | - | Series B Warrants (right to buy) | |
| Enterprise Products Partners L P - Unit | A. James Teague | Director, CO-CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 275,000 | 275,000 | - | - | Phantom Units | |
| Enterprise Products Partners L P - Unit | W. Randall Fowler | Director, CO-CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 275,000 | 275,000 | - | - | Phantom Units | |
| GSK PLC (ADR) | Emma N. Walmsley | Executive Director,Chief Executive Officer | 10 Feb 2025 | 256,706 | 671,366 (0%) | 0% | 0 | Ords 0.31p | ||
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 252,628 | 785,607 | - | - | Common Stock | |
| ImmunityBio Inc | David C. Sachs | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 246,710 | 246,710 | - | - | Restricted Stock Units | |
| Veritone Inc | Ryan Steelberg | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 240,000 | 906,073 (3%) | 0% | 0 | Common Stock | |
| Constellation Energy | Joseph Dominguez | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 236,558 | 319,613 | - | - | Common Stock | |
| Johnson Controls | George R. Oliver | Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.39 per share. | 10 Feb 2025 | 205,168 | 1,465,694 (0%) | 0% | 33.4 | 6,850,560 | Ordinary Shares |
| Johnson Controls | George R. Oliver | Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 205,168 | 148,533 | - | - | Employee Stock Option (Right to Buy) | |
| Johnson Controls | George R. Oliver | Chairman & CEO | Sale of securities on an exchange or to another person at price $ 89.06 per share. | 10 Feb 2025 | 202,768 | 1,262,926 (0%) | 0% | 89.1 | 18,058,518 | Ordinary Shares |
| Constellation Energy | Joseph Dominguez | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 197,294 | 0 | - | - | 2022-2024 Performance Shares | |
| Constellation Energy | Joseph Dominguez | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 197,294 | 197,294 | - | - | 2022-2024 Performance Shares | |
| United Airlines Holdings | J. Scott Kirby | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 195,512 | 679,212 (0%) | 0% | 0 | Common Stock | |
| SES AI Corp (Class A) | Qichao Hu | Director, CEO & CHAIRMAN, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 10 Feb 2025 | 194,459 | 2,781,769 | - | 1.2 | 227,770 | Class A Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 187,760 | 375,521 | - | - | Restricted Stock Units | |
| Solid Power Inc (Class A) | Joshua R. Buettner-Garrett | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 10 Feb 2025 | 187,500 | 1,052,804 | - | 0.0 | 5,625 | Common Stock |
| Solid Power Inc (Class A) | Joshua R. Buettner-Garrett | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 1.31 per share. | 10 Feb 2025 | 187,500 | 865,304 | - | 1.3 | 246,413 | Common Stock |
| Solid Power Inc (Class A) | Joshua R. Buettner-Garrett | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 187,500 | 187,500 | - | - | Stock Option (Right to Buy) | |
| Johnson Controls | George R. Oliver | Chairman & CEO | Sale of securities on an exchange or to another person at price $ 89.09 per share. | 10 Feb 2025 | 187,309 | 1,221,750 (0%) | 0% | 89.1 | 16,687,359 | Ordinary Shares |
| Freshpet Inc | William B. Cyr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 177,025 | 177,025 | - | - | Options to purchase common stock | |
| Lyell Immunopharma Inc | Seely Lynn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 168,750 | 168,750 | - | - | Option (right to buy) | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 150,240 | 8,613,327 | - | - | Class B Common Stock | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 150,240 | 600,960 | - | - | Stock Option (Right to Buy) | |
| Iovance Biotherapeutics Inc | Daniel Gordon Kirby | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 150,000 | 150,000 | - | - | Performance Stock Units | |
| Johnson Controls | George R. Oliver | Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 148,533 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Johnson Controls | George R. Oliver | Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.39 per share. | 10 Feb 2025 | 148,533 | 1,409,059 (0%) | 0% | 33.4 | 4,959,517 | Ordinary Shares |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.76 per share. | 10 Feb 2025 | 139,064 | 1,160,634 (0%) | 0% | 1.8 | 244,753 | Class A Common Stock |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.22 per share. | 10 Feb 2025 | 133,905 | 2,251,943 | - | 14.2 | 1,904,625 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Michael Shetzline | SVP, CMO, Head-Res&Drug | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 133,333 | 595,276 (0%) | 0% | 0 | Class A Common Stock | |
| Freshpet Inc | Scott Morris | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 132,768 | 132,768 | - | - | Options to purchase common stock | |
| Ingersoll Rand | Vicente Reynal | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 131,850 | 232,217 (0%) | 0% | 0 | Common Stock | |
| Warrior Met Coal Inc | Walter Scheller | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 128,055 | 466,114 (0%) | 0% | 0 | Common Stock | |
| Ironwood Pharma Inc (Class A) | John Minardo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 122,222 | 447,070 (0%) | 0% | 0 | Class A Common Stock | |
| GSK PLC (ADR) | Emma N. Walmsley | Executive Director,Chief Executive Officer | 10 Feb 2025 | 120,653 | 550,713 (0%) | 0% | 14.5 | 1,753,317 | Ords 0.31p | |
| Iovance Biotherapeutics Inc | Daniel Gordon Kirby | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 120,000 | 120,000 | - | - | Restricted Stock Units | |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 117,505 | 117,505 | - | - | Stock Option (Right to Buy) | |
| United Airlines Holdings | Brett J. Hart | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 113,642 | 289,845 (0%) | 0% | 0 | Common Stock | |
| Lyell Immunopharma Inc | Lee Gary | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 112,500 | 176,696 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Hill Stephen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 112,500 | 172,899 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Charles Newton W. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 112,500 | 172,725 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Lang Matthew | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 112,500 | 162,500 | - | 0 | Common Stock | |
| Roblox Corp (Class A) | Michael Guthrie | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 112,046 | 0 | - | - | Performance Stock Unit | |
| Roblox Corp (Class A) | Michael Guthrie | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 112,046 | 443,233 | - | 0 | Class A Common Stock | |
| Roblox Corp (Class A) | Manuel Bronstein | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 112,046 | 0 | - | - | Performance Stock Unit | |
| Roblox Corp (Class A) | Manuel Bronstein | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 112,046 | 685,312 | - | 0 | Class A Common Stock | |
| Constellation Energy | Joseph Dominguez | Director, President & CEO | Sale or transfer of securities back to the company at price $ 321.83 per share. | 10 Feb 2025 | 111,092 | 105,640 | - | 321.8 | 35,752,738 | Common Stock |
| Yum Brands | David W. Gibbs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 107,082 | 107,082 | - | - | Stock Appreciation Right | |
| Yum China Holdings Inc | Joey Wat | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 104,015 | 104,015 | - | - | Restricted Stock Unit | |
| Constellation Energy | Joseph Dominguez | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.83 per share. | 10 Feb 2025 | 102,880 | 216,732 | - | 321.8 | 33,109,870 | Common Stock |
| Amcor | Peter Konieczny | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 10.05 per share. | 10 Feb 2025 | 100,000 | 459,395 (0%) | 0% | 10.0 | 1,004,780 | Ordinary Shares |
| Prudential Financial | Charles F. Lowrey | Director, Chief Executive Officer, Chairman of the Board | 10 Feb 2025 | 93,675 | 93,675 | - | - | 2025 Performance Shares | ||
| Devon Energy | Clay M. Gaspar | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 93,404 | 500,040 (0%) | 0% | 0 | Common Stock | |
| TriSalus Life Sciences Inc | David J. Matlin | Director | Other type of transaction at price $ 0.00 per share. | 10 Feb 2025 | 89,501 | 189,501 | - | - | Series A Preferred Stock | |
| International Paper | Timothy S. Nicholls | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 89,099 | 280,821 (0%) | 0% | 0 | Common Stock | |
| Lattice Semiconductor Corp | Lorenzo A. Flores | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 88,646 | 106,375 (0%) | 0% | 0 | Common Stock | |
| Allison Transmission Holdings Inc | David S. Graziosi | Director, Chair, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 88,600 | 88,600 | - | - | Performance Stock Units | |
| Janover Inc | William J. Caragol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 87,500 | 87,500 | - | - | Stock Option (Right to buy) | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | 10 Feb 2025 | 85,637 | 465,330 (0%) | 0% | 0.3 | 26,265 | Class A Common Stock | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | 10 Feb 2025 | 85,637 | 8,527,690 | - | - | Class B Common Stock | ||
| Grindr Inc (Class A) | J. Michael Gearon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Feb 2025 | 84,964 | 26,977 | - | - | Warrants | |
| DraftKings Inc (Class A) | Alan Ellingson W. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 84,807 | 84,807 | - | - | Restricted Stock Units | |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 175.85 per share. | 10 Feb 2025 | 84,159 | 2,431,194 | - | 175.8 | 14,799,360 | Class A Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.92 per share. | 10 Feb 2025 | 83,660 | 701,947 | - | 0.9 | 77,319 | Common Stock |
| Enterprise Products Partners L P - Unit | R. Daniel Boss | EXECUTIVE VICE PRESIDENT & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 82,700 | 82,700 | - | - | Phantom Units | |
| Veritone Inc | Michael L. Zemetra | EVP, CFO & TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 82,500 | 294,462 (1%) | 0% | 0 | Common Stock | |
| Enterprise Products Partners L P - Unit | Harry P. Weitzel | Director, EVP, GENERAL COUNSEL & SEC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 82,000 | 82,000 | - | - | Phantom Units | |
| Prudential Financial | Robert M. Falzon | EVP and Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 81,631 | 81,631 | - | - | 2025 Performance Shares | |
| SES AI Corp (Class A) | Jing Nealis | CHIEF FINANCIAL OFFICER | 10 Feb 2025 | 80,992 | 1,841,637 | - | 1.2 | 94,866 | Class A Common Stock | |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 78,337 | 160,402 | - | 0 | Common Stock | |
| Alliance Resource Partners, LP - Unit | Kirk D. Tholen | SENIOR VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 78,003 | 0 | - | - | Restricted unit | |
| Alliance Resource Partners, LP - Unit | Kirk D. Tholen | SENIOR VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 78,003 | 188,399 (0%) | 0% | - | Common unit | |
| Enterprise Products Partners L P - Unit | Christian M. Nelly | EVP-FIN/SUSTAIN. AND TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 77,600 | 77,600 | - | - | Phantom Units | |
| Roblox Corp (Class A) | Mark Reinstra | Chief Legal Off. & Corp. Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 77,570 | 0 | - | - | Performance Stock Unit | |
| Roblox Corp (Class A) | Mark Reinstra | Chief Legal Off. & Corp. Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 77,570 | 358,731 | - | 0 | Class A Common Stock | |
| Prudential Financial | Charles F. Lowrey | Director, Chief Executive Officer, Chairman of the Board | 10 Feb 2025 | 77,269 | 0 | - | - | 2022 Performance Shares | ||
| Skywest Inc | Russell Childs A. | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.32 per share. | 10 Feb 2025 | 77,103 | 466,242 (0%) | 0% | 113.3 | 8,737,312 | Common Stock |
| United Airlines Holdings | J. Scott Kirby | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.08 per share. | 10 Feb 2025 | 75,542 | 603,670 (0%) | 0% | 106.1 | 8,013,495 | Common Stock |
| Arcus Biosciences Inc | Richard Markus | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 75,193 | 75,193 (0%) | 0% | 0 | Common Stock | |
| Enterprise Products Partners L P - Unit | Graham W. Bacon | EXECUTIVE VICE PRESIDENT & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 75,000 | 75,000 | - | - | Phantom Units | |
| Enterprise Products Partners L P - Unit | Brent B. Secrest | EVP & CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 73,500 | 73,500 | - | - | Phantom Units | |
| Freshpet Inc | Thembeka Machaba | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 70,810 | 70,810 | - | - | Options to purchase common stock | |
| Janover Inc | Marcelo Lemos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 69,650 | 69,650 | - | - | Stock Option (Right to buy) | |
| Biodesix Inc | Robin Harper Cowie | CFO, Secy & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 67,788 | 271,124 | - | - | Common Stock | |
| Prudential Financial | Charles F. Lowrey | Director, Chief Executive Officer, Chairman of the Board | 10 Feb 2025 | 62,975 | 233,056 (0%) | 0% | 0 | Common Stock | ||
| Prudential Financial | Robert M. Falzon | EVP and Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 61,815 | 0 | - | - | 2022 Performance Shares | |
| Sionna Therapeutics Inc | Bruce Booth | Director | 10 Feb 2025 | 61,463 | 0 | - | - | Series C convertible preferred stock | ||
| NextTrip Inc | John Patrick McMahon | Chief Operating Officer | Other type of transaction at price $ 0.00 per share. | 10 Feb 2025 | 61,243 | 122,486 | - | - | Series O Nonvoting Convertible Preferred Stock | |
| NextTrip Inc | John Patrick McMahon | Chief Operating Officer | Other type of transaction at price $ 0.00 per share. | 10 Feb 2025 | 61,243 | 61,243 | - | - | Series O Nonvoting Convertible Preferred Stock | |
| Sunstone Hotel Investors Inc | Bryan A. Giglia | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 60,293 | 701,146 (0%) | 0% | - | Common Stock | |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 175.42 per share. | 10 Feb 2025 | 60,269 | 2,559,952 | - | 175.4 | 10,572,388 | Class A Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 10 Feb 2025 | 60,000 | 807,727 | - | 18 | 1,080,000 | Common Stock |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.56 per share. | 10 Feb 2025 | 60,000 | 2,191,943 | - | 14.6 | 873,618 | Class A Common Stock |
| Warrior Met Coal Inc | Walter Scheller | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.39 per share. | 10 Feb 2025 | 56,793 | 409,321 (0%) | 0% | 53.4 | 3,032,178 | Common Stock |
| ImmunityBio Inc | Regan Lauer | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 56,250 | 56,250 | - | - | Stock Option (right to buy) | |
| Lyell Immunopharma Inc | Lang Matthew | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 56,250 | 56,250 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Hill Stephen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 56,250 | 56,250 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Gary Lee | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 56,250 | 56,250 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Newton Charles W. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 56,250 | 56,250 | - | - | Option (right to buy) | |
| Ingersoll Rand | Vicente Reynal | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.18 per share. | 10 Feb 2025 | 56,015 | 176,202 (0%) | 0% | 92.2 | 5,163,463 | Common Stock |
| Constellation Energy | Daniel Eggers | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 55,669 | 79,372 | - | - | Common Stock | |
| Eli Lilly | David A. Ricks | Director, President, Chair, and CEO | Grant, award, or other acquisition of securities at price $ 868.89 per share. | 10 Feb 2025 | 55,131 | 539,613 (0%) | 0% | 868.9 | 47,902,710 | Common Stock |
| Alliance Resource Partners, LP - Unit | Thomas M. Wynne | SENIOR VICE PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 54,602 | 914,541 (0%) | 0% | - | Common unit | |
| Alliance Resource Partners, LP - Unit | Thomas M. Wynne | SENIOR VICE PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 54,602 | 0 | - | - | Restricted unit | |
| Yum Brands | David W. Gibbs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 54,424 | 208,601 (0%) | 0% | 0 | Common Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 52,656 | 157,969 | - | - | Restricted Stock Units | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 147.23 per share. | 10 Feb 2025 | 52,640 | 379,693 (0%) | 0% | 147.2 | 7,750,235 | Class A Common Stock |
| Collegium pharma Inc | Colleen Tupper | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 51,768 | 182,613 (0%) | 0% | 0 | Common Stock | |
| Constellation Energy | James McHugh | EVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 51,721 | 87,722 | - | - | Common Stock | |
| SES AI Corp (Class A) | Hong Gan | CHIEF SCIENCE OFFICER | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 10 Feb 2025 | 51,600 | 773,906 | - | 1.2 | 60,439 | Class A Common Stock |
| United Airlines Holdings | Andrew P. Nocella | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 51,321 | 161,120 (0%) | 0% | 0 | Common Stock | |
| United Airlines Holdings | Kate Gebo | EVP HR and Labor Relations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 51,321 | 91,333 (0%) | 0% | 0 | Common Stock | |
| United Airlines Holdings | Torbjorn J. Enqvist | EVP & Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 51,321 | 81,748 (0%) | 0% | 0 | Common Stock | |
| Corebridge Fin Inc | Polly N. Klane | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 50,598 | 50,598 | - | 0 | Common Stock | |
| Host Hotels & Resorts - REIT | James F. Risoleo | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.55 per share. | 10 Feb 2025 | 50,579 | 2,367,543 (0%) | 0% | 16.5 | 837,082 | Common Stock |
| Prudential Financial | Robert M. Falzon | EVP and Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 50,380 | 260,411 (0%) | 0% | 0 | Common Stock | |
| Annaly Cap Management Inc | David L. Finkelstein | Director, CEO and Co-CIO | Sale of securities on an exchange or to another person at price $ 20.60 per share. | 10 Feb 2025 | 50,000 | 677,465 (0%) | 0% | 20.6 | 1,030,000 | Common Stock |
| Flex Ltd | Lay Koon Tan | Director | Sale of securities on an exchange or to another person at price $ 43.25 per share. | 10 Feb 2025 | 50,000 | 202,850 (0%) | 0% | 43.3 | 2,162,500 | Ordinary Shares |
| United Airlines Holdings | Brett J. Hart | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.08 per share. | 10 Feb 2025 | 48,964 | 240,881 (0%) | 0% | 106.1 | 5,194,101 | Common Stock |
| Biodesix Inc | Robin Harper Cowie | CFO, Secy & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 48,536 | 97,070 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 48,118 | 145,566 | - | - | Common Stock | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.45 per share. | 10 Feb 2025 | 48,000 | 5,198,096 | - | 7.5 | 357,600 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 48,000 | 1,188,799 | - | - | Employee Stock Option (Right to Buy) | |
| Alliance Resource Partners, LP - Unit | Timothy J. Whelan | SENIOR VICE PRESIDENT SALES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 46,802 | 0 | - | - | Restricted unit | |
| Alliance Resource Partners, LP - Unit | Timothy J. Whelan | SENIOR VICE PRESIDENT SALES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 46,802 | 164,748 (0%) | 0% | - | Common unit | |
| Constellation Energy | Daniel Eggers | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 46,230 | 0 | - | - | 2022-2024 Performance Shares | |
| Constellation Energy | Daniel Eggers | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 46,230 | 46,230 | - | - | 2022-2024 Performance Shares | |
| NextTrip Inc | John Patrick McMahon | Chief Operating Officer | Other type of transaction at price $ 0.00 per share. | 10 Feb 2025 | 45,930 | 168,416 | - | - | Series O Nonvoting Convertible Preferred Stock | |
| Biodesix Inc | Gary Pestano | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 45,729 | 172,756 | - | - | Common Stock | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 146.72 per share. | 10 Feb 2025 | 45,371 | 432,333 (0%) | 0% | 146.7 | 6,656,978 | Class A Common Stock |
| MACOM Tech Soln Holdings Inc | Susan Ocampo | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 125.34 per share. | 10 Feb 2025 | 45,371 | 5,510,148 (8%) | 0% | 125.3 | 5,686,801 | Common Stock |
| Live Oak Bancshares Inc | William C. Losch | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 45,153 | 45,153 | - | - | Restricted Stock Units | |
| Collegium pharma Inc | Scott Dreyer | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 45,016 | 150,918 (0%) | 0% | 0 | Common Stock | |
| TriSalus Life Sciences Inc | Mats L. Wahlstrom | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Feb 2025 | 44,750 | 94,750 | - | - | Series A Convertible Preferred Stock | |
| Devon Energy | Jeffrey L. Ritenour | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 44,367 | 465,479 (0%) | 0% | 0 | Common Stock | |
| SES AI Corp (Class A) | Kyle Pilkington | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 10 Feb 2025 | 44,051 | 496,580 | - | 1.2 | 51,597 | Class A Common Stock |
| Constellation Energy | James McHugh | EVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 43,874 | 0 | - | - | 2022-2024 Performance Shares | |
| Constellation Energy | James McHugh | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 43,874 | 43,874 | - | - | 2022-2024 Performance Shares | |
| Warrior Met Coal Inc | Jack K. Richardson | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 42,509 | 203,277 (0%) | 0% | 0 | Common Stock | |
| Constellation Energy | Kathleen Barron | EVP & Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 41,579 | 65,634 | - | - | Common Stock | |
| Bancorp Inc | Damian M. Kozlowski | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 41,493 | 679,874 (1%) | 0% | - | Common Stock | |
| Ironwood Pharma Inc (Class A) | Michael Shetzline | SVP, CMO, Head-Res&Drug | Sale of securities on an exchange or to another person at price $ 1.76 per share. | 10 Feb 2025 | 41,269 | 554,007 (0%) | 0% | 1.8 | 72,633 | Class A Common Stock |
| Andersons Inc | Patrick E. Bowe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 41,108 | 140,192 (0%) | 0% | 0 | Common Stock | |
| Andersons Inc | Patrick E. Bowe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 41,108 | 0 | - | - | PERFORMANCE SHARE UNIT (EPS) (2025) | |
| Neuronetics Inc | Keith J. Sullivan | Director, President and CEO | 10 Feb 2025 | 40,992 | 1,283,362 (6%) | 0% | 3.3 | 134,454 | Common Stock | |
| Collegium pharma Inc | Shirley R. Kuhlmann | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 40,965 | 160,149 (0%) | 0% | 0 | Common Stock | |
| Sunstone Hotel Investors Inc | Robert C. Springer | PRESIDENT AND CIO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 40,913 | 609,898 (0%) | 0% | - | Common Stock | |
| PC Connection Inc | Timothy J. McGrath | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Meridian Holdings Inc | Aleksandar Milovanovic | Ten Percent Owner, Member of 10% Reporting Group | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 10 Feb 2025 | 40,000 | 77,994,616 | - | 1.9 | 74,000 | Common Stock |
| IQVIA | Ari Bousbib | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.16 per share. | 10 Feb 2025 | 40,000 | 837,083 (0%) | 0% | 65.2 | 2,606,400 | Common Stock |
| IQVIA | Ari Bousbib | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 40,000 | 0 | - | - | Stock Appreciation Right | |
| LiveRamp Holdings Inc | Vihan Sharma | CHIEF REVENUE OFFICER | Sale of securities on an exchange or to another person at price $ 35.56 per share. | 10 Feb 2025 | 39,845 | 110,902 (0%) | 0% | 35.6 | 1,416,888 | COMMON STOCK, $.10 PAR VALUE |
| SiTime Corp | Rajesh Vashist | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 39,651 | 524,281 (3%) | 0% | 0 | Common Stock | |
| Symbotic Inc (Class A) | Todd Krasnow | Director | Other type of transaction at price $ 0.00 per share. | 10 Feb 2025 | 39,553 | 657,019 | - | - | Class V-1 Common Stock | |
| Symbotic Inc (Class A) | Todd Krasnow | Director | Other type of transaction at price $ 0.00 per share. | 10 Feb 2025 | 39,553 | 657,019 | - | - | Symbotic Holdings Units | |
| Symbotic Inc (Class A) | Todd Krasnow | Director | Sale of securities on an exchange or to another person at price $ 27.27 per share. | 10 Feb 2025 | 39,553 | 0 | - | 27.3 | 1,078,804 | Class A Common Stock |
| Symbotic Inc (Class A) | Todd Krasnow | Director | Other type of transaction at price $ 0.00 per share. | 10 Feb 2025 | 39,553 | 39,553 | - | - | Class A Common Stock | |
| Constellation Energy | Joseph Dominguez | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 39,264 | 31,777 | - | - | Restricted Stock Units | |
| FVCBankcorp Inc | Patricia A. Ferrick | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 39,062 | 0 | - | - | Stock Options | |
| FVCBankcorp Inc | Patricia A. Ferrick | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.85 per share. | 10 Feb 2025 | 39,062 | 200,144 (1%) | 0% | 6.9 | 267,594 | Common Stock |
| Ironwood Pharma Inc (Class A) | John Minardo | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 1.76 per share. | 10 Feb 2025 | 38,938 | 408,132 (0%) | 0% | 1.8 | 68,531 | Class A Common Stock |
| Carvana Co. (Class A) | Paul Breaux | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 38,638 | 239,334 | - | - | Stock Options (Right to Buy) | |
| Carvana Co. (Class A) | Paul Breaux | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.07 per share. | 10 Feb 2025 | 38,638 | 191,878 (0%) | 0% | 10.1 | 389,085 | Class A Common Stock |
| Cheesecake Factory Inc | David Overton | Director, CHAIRMAN AND C.E.O. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.01 per share. | 10 Feb 2025 | 38,530 | 3,007,330 (6%) | 0% | 53.0 | 2,042,475 | Common Stock |
| Zions Bancorp N.A | Harris H. Simmons | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 56.03 per share. | 10 Feb 2025 | 38,166 | 1,307,374 (0%) | 0% | 56.0 | 2,138,441 | Common Stock |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 38,118 | 8,565,808 | - | - | Class B Common Stock | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 38,118 | 1,219,764 | - | - | Stock Option (Right to Buy) | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 71.33 per share. | 10 Feb 2025 | 37,672 | 5,150,696 | - | 71.3 | 2,686,978 | Common Stock |
| Constellation Energy | David Dardis | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 37,362 | 58,509 | - | - | Common Stock | |
| Helmerich & Payne Inc | Belgacem Chariag | Director | Purchase of securities on an exchange or from another person at price $ 27.08 per share. | 10 Feb 2025 | 37,356 | 54,606 (0%) | 0% | 27.1 | 1,011,600 | Common Stock |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 174.77 per share. | 10 Feb 2025 | 37,107 | 2,499,683 | - | 174.8 | 6,485,190 | Class A Common Stock |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 173.32 per share. | 10 Feb 2025 | 37,053 | 2,286,048 | - | 173.3 | 6,422,026 | Class A Common Stock |
| Constellation Energy | Michael R. Koehler | EVP & Chief Admin Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 36,802 | 72,031 | - | - | Common Stock | |
| Warrior Met Coal Inc | Dale W. Boyles | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 36,246 | 180,824 (0%) | 0% | 0 | Common Stock | |
| Disc Medicine Inc | Jean M. Franchi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 36,000 | 72,666 | - | 0 | Common Stock | |
| Disc Medicine Inc | Jean M. Franchi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | Pamela Stephenson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | Pamela Stephenson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 36,000 | 72,666 | - | 0 | Common Stock | |
| Disc Medicine Inc | Rahul Khara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | Jonathan Yu | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Iovance Biotherapeutics Inc | Daniel Gordon Kirby | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 35,000 | 35,000 | - | - | Stock Options (Right to Buy) | |
| Constellation Energy | Kathleen Barron | EVP & Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 34,836 | 34,836 | - | - | 2022-2024 Performance Shares | |
| Constellation Energy | Kathleen Barron | EVP & Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 34,836 | 0 | - | - | 2022-2024 Performance Shares | |
| Alliance Resource Partners, LP - Unit | Kirk D. Tholen | SENIOR VICE PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.28 per share. | 10 Feb 2025 | 34,622 | 153,777 (0%) | 0% | 27.3 | 944,488 | Common unit |
| International Paper | Timothy S. Nicholls | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.07 per share. | 10 Feb 2025 | 34,096 | 246,725 (0%) | 0% | 56.1 | 1,911,763 | Common Stock |
| Collegium pharma Inc | Thomas B. Smith | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 33,762 | 88,326 (0%) | 0% | 0 | Common Stock | |
| Yum Brands | Tracy L. Skeans | COO and CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 33,750 | 33,750 | - | - | Restricted Stock Units | |
| Yum Brands | Sean Tresvant C. | Taco Bell, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 33,750 | 33,750 | - | - | Restricted Stock Units | |
| Prudential Financial | Charles F. Lowrey | Director, Chief Executive Officer, Chairman of the Board | 10 Feb 2025 | 33,517 | 199,539 (0%) | 0% | 112.1 | 3,756,921 | Common Stock | |
| Prudential Financial | Andrew F. Sullivan | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 33,456 | 33,456 | - | - | 2025 Performance Shares | |
| Devon Energy | Richard E. Muncrief | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.26 per share. | 10 Feb 2025 | 33,253 | 2,015,155 (0%) | 0% | 34.3 | 1,139,248 | Common Stock |
| United Community Banks Inc | H. Lynn Harton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 33,215 | 199,219 (0%) | 0% | 0 | Common Stock | |
| Bancorp Inc | Ryan Harris | EVP Head of Fintech Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 33,195 | 158,448 (0%) | 0% | - | Common Stock | |
| Neostellar Capital Corp | Mark D. Klein | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.17 per share. | 10 Feb 2025 | 32,858 | 1,199,519 (6%) | 0% | 6.2 | 202,734 | Common Stock |
| Bancorp Inc | Damian M. Kozlowski | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 32,624 | 32,624 | - | - | Stock Option (right to buy) | |
| International Paper | William Thomas Hamic | Exec. VP & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 32,597 | 130,516 (0%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | Douglas Valenti | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2025 | 32,400 | 1,850,785 (3%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | Douglas Valenti | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2025 | 32,400 | 630,130 (1%) | 0% | 0 | Common Stock | |
| Eli Lilly | David A. Ricks | Director, President, Chair, and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 31,932 | 31,932 | - | - | Restricted Stock Unit | |
| Candel Therapeutics Inc | Estuardo Aguilar-Cordova | Ten Percent Owner | Sale or transfer of securities back to the company at price $ 8.61 per share. | 10 Feb 2025 | 31,335 | 60,000 | - | 8.6 | 269,794 | CADL |
| Constellation Energy | Michael R. Koehler | EVP & Chief Admin Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 31,300 | 0 | - | - | 2022-2024 Performance Shares | |
| Constellation Energy | Michael R. Koehler | EVP & Chief Admin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 31,300 | 31,300 | - | - | 2022-2024 Performance Shares | |
| Prudential Financial | Charles F. Lowrey | Director, Chief Executive Officer, Chairman of the Board | 10 Feb 2025 | 31,225 | 31,225 | - | - | 2025 Restricted Stock Units | ||
| Constellation Energy | David Dardis | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 30,940 | 0 | - | - | 2022-2024 Performance Shares | |
| Constellation Energy | David Dardis | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 30,940 | 30,940 | - | - | 2022-2024 Performance Shares | |
| United Community Banks Inc | H. Lynn Harton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 33.84 per share. | 10 Feb 2025 | 30,721 | 113,402 (0%) | 0% | 33.8 | 1,039,470 | Common Stock |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 10 Feb 2025 | 30,699 | 30,699 (0%) | 0% | 0 | Class A Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 10 Feb 2025 | 30,699 | 192,999,382 | - | - | Class B Common Stock | ||
| AT&T | Michael B. McCallister | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2025 | 30,566 | 62,076 (0%) | 0% | 0 | Common Stock | |
| AT&T | Michael B. McCallister | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2025 | 30,566 | 0 (0%) | 0% | 0 | Common Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 30,534 | 61,067 | - | - | Restricted Stock Units | |
| Devon Energy | Dennis C. Cameron | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 30,357 | 286,482 (0%) | 0% | 0 | Common Stock | |
| MDU Resources Grp Inc | Dennis W. Johnson | Director | Purchase of securities on an exchange or from another person at price $ 16.64 per share. | 10 Feb 2025 | 30,000 | 180,166 (0%) | 0% | 16.6 | 499,200 | Common Stock |
| Yum Brands | Tracy L. Skeans | COO and CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 29,269 | 29,269 | - | - | Stock Appreciation Right | |
| Yum Brands | Aaron M. Powell | CEO - Pizza Hut | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 29,269 | 29,269 | - | - | Stock Appreciation Right | |
| Yum Brands | Christopher L. Turner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 29,269 | 29,269 | - | - | Stock Appreciation Right | |
| Yum Brands | Sean Tresvant C. | Taco Bell, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 29,269 | 29,269 | - | - | Stock Appreciation Right | |
| Alliance Resource Partners, LP - Unit | Cary P. Marshall | SENIOR VP AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 29,173 | 1,013,795 (0%) | 0% | - | Common unit | |
| Alliance Resource Partners, LP - Unit | Cary P. Marshall | SENIOR VP AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 29,173 | 0 | - | - | Restricted unit | |
| Prudential Financial | Caroline A. Feeney | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 29,107 | 29,107 | - | - | 2025 Performance Shares | |
| Warrior Met Coal Inc | Kelli K. Gant | CHIEF ADMINISTRATIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 29,093 | 92,317 (0%) | 0% | 0 | Common Stock | |
| Collegium pharma Inc | Shirley R. Kuhlmann | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 29,030 | 189,179 (0%) | 0% | 0 | Common Stock | |
| Honeywell | Anne T. Madden | SrVP and General Counsel | 10 Feb 2025 | 28,885 | 41,580 (0%) | 0% | 207.9 | 6,004,903 | Common Stock | |
| Honeywell | Anne T. Madden | SrVP and General Counsel | 10 Feb 2025 | 28,885 | 70,465 (0%) | 0% | 98.7 | 2,850,950 | Common Stock | |
| Honeywell | Anne T. Madden | SrVP and General Counsel | 10 Feb 2025 | 28,885 | 0 | - | - | Employee Stock Options (right to buy) | ||
| Dominari Holdings Inc | Christopher Franklin Devall | COO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Feb 2025 | 28,818 | 28,818 | - | - | Series B Warrants (right to buy) | |
| Dominari Holdings Inc | Christopher Franklin Devall | COO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Feb 2025 | 28,818 | 58,851 (1%) | 0% | - | Common Stock | |
| Dominari Holdings Inc | Christopher Franklin Devall | COO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Feb 2025 | 28,818 | 28,818 | - | - | Series A Warrants (right to buy) | |
| Loop Ind Inc | Spencer Hart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 28,770 | 30,770 (0%) | 0% | 0 | Common Stock | |
| Carvana Co. (Class A) | Paul Breaux | See Remarks | Sale of securities on an exchange or to another person at price $ 270.34 per share. | 10 Feb 2025 | 28,519 | 163,359 (0%) | 0% | 270.3 | 7,709,826 | Class A Common Stock |
| Biodesix Inc | Gary Pestano | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 28,256 | 56,510 | - | - | Restricted Stock Units | |
| SES AI Corp (Class A) | Kang Xu | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 10 Feb 2025 | 27,969 | 444,290 | - | 1.2 | 32,760 | Class A Common Stock |
| Healthcare Realty Trust Inc (Class A) | Austen B. Helfrich | EVP and CFO | Grant, award, or other acquisition of securities at price $ 16.17 per share. | 10 Feb 2025 | 27,829 | 55,359 (0%) | 0% | 16.2 | 449,995 | Common Stock |
| International Paper | Clayton R. Ellis | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 27,651 | 77,520 (0%) | 0% | 0 | Common Stock | |
| Allstate | Jesse E. Merten | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 186.03 per share. | 10 Feb 2025 | 27,315 | 30,902 (0%) | 0% | 186.0 | 5,081,314 | Common Stock |
| Prudential Financial | Robert M. Falzon | EVP and Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 27,211 | 27,211 | - | - | 2025 Restricted Stock Units | |
| Prudential Financial | Andrew F. Sullivan | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 27,199 | 0 | - | - | 2022 Performance Shares | |
| International Paper | Joseph R. Saab | SVP, GC and Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 27,056 | 44,973 (0%) | 0% | 0 | Common Stock | |
| Collegium pharma Inc | Colleen Tupper | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 26,957 | 209,570 (0%) | 0% | 0 | Common Stock | |
| Skywest Inc | Robert J. Simmons | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.32 per share. | 10 Feb 2025 | 26,864 | 148,203 (0%) | 0% | 113.3 | 3,044,228 | Common Stock |
| Procept BioRobotics Corp | Frederic H. Moll | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.33 per share. | 10 Feb 2025 | 26,749 | 836,358 | - | 1.3 | 35,576 | Common Stock |
| Procept BioRobotics Corp | Frederic H. Moll | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 26,749 | 0 | - | - | Stock Option (Right to Buy) | |
| Intercontinental Exchange | Jeffrey C. Sprecher | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 26,702 | 1,200,696 (0%) | 0% | 0 | Common Stock | |
| IQVIA | Ari Bousbib | Director, See Remarks | Sale or transfer of securities back to the company at price $ 206.97 per share. | 10 Feb 2025 | 26,585 | 810,498 (0%) | 0% | 207.0 | 5,502,297 | Common Stock |
| Skywest Inc | Wade J. Steel | CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.32 per share. | 10 Feb 2025 | 26,562 | 134,416 (0%) | 0% | 113.3 | 3,010,006 | Common Stock |
| Constellation Energy | Daniel Eggers | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.83 per share. | 10 Feb 2025 | 26,438 | 52,934 | - | 321.8 | 8,508,542 | Common Stock |
| Collegium pharma Inc | Scott Dreyer | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 26,411 | 177,329 (0%) | 0% | 0 | Common Stock | |
| Ingersoll Rand | Vikram U. Kini | Senior Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 26,370 | 93,508 (0%) | 0% | 0 | Common Stock | |
| Roblox Corp (Class A) | Michael Guthrie | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 65.94 per share. | 10 Feb 2025 | 26,154 | 417,079 | - | 65.9 | 1,724,673 | Class A Common Stock |
| Roblox Corp (Class A) | Manuel Bronstein | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 65.94 per share. | 10 Feb 2025 | 26,149 | 659,163 | - | 65.9 | 1,724,268 | Class A Common Stock |
| Insmed Inc | Roger Adsett | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 79.33 per share. | 10 Feb 2025 | 26,141 | 146,082 (0%) | 0% | 79.3 | 2,073,766 | Common Stock |
| Sunstone Hotel Investors Inc | Aaron R. Reyes | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 25,840 | 113,671 (0%) | 0% | - | Common Stock | |
| Cytokinetics Inc | Robert E. Landry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 25,538 | 25,538 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Yum Brands | David W. Gibbs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 25,313 | 25,313 | - | - | Restricted Stock Units | |
| Collegium pharma Inc | Shirley R. Kuhlmann | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.52 per share. | 10 Feb 2025 | 25,149 | 154,204 (0%) | 0% | 30.5 | 767,547 | Common Stock |
| MACOM Tech Soln Holdings Inc | Susan Ocampo | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 123.32 per share. | 10 Feb 2025 | 25,003 | 5,484,743 (8%) | 0% | 123.3 | 3,083,370 | Common Stock |
| eXp World Holdings Inc | Glenn Sanford | Director, CEO and Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.96 per share. | 10 Feb 2025 | 25,000 | 39,968,400 (62%) | 0% | 11.0 | 274,078 | Common Stock |
| Core & Main Inc (Class A) | Bradford A. Cowles | President | 10 Feb 2025 | 25,000 | 41,010 | - | 0 | Class A Common Stock | ||
| Core & Main Inc (Class A) | Bradford A. Cowles | President | Sale of securities on an exchange or to another person at price $ 54.48 per share. | 10 Feb 2025 | 25,000 | 16,010 | - | 54.5 | 1,362,083 | Class A Common Stock |
| Core & Main Inc (Class A) | Bradford A. Cowles | President | Other type of transaction at price $ 0.00 per share. | 10 Feb 2025 | 25,000 | 798,456 | - | - | Class B Common Stock and Limited Partnership Interests | |
| Core & Main Inc (Class A) | Bradford A. Cowles | President | Other type of transaction at price $ 0.00 per share. | 10 Feb 2025 | 25,000 | 25,000 | - | - | Class B Common Stock and Limited Partnership Interests | |
| Core & Main Inc (Class A) | Bradford A. Cowles | President | 10 Feb 2025 | 25,000 | 0 | - | - | Class B Common Stock and Limited Partnership Interests | ||
| Roku Inc (Class A) | Anthony Wood | Director, CEO and Chairman BOD, Ten Percent Owner | 10 Feb 2025 | 25,000 | 16,978,111 | - | - | Class B Common Stock | ||
| Roku Inc (Class A) | Anthony Wood | Director, CEO and Chairman BOD, Ten Percent Owner | 10 Feb 2025 | 25,000 | 51,538 (0%) | 0% | - | Class A Common Stock | ||
| Andersons Inc | Patrick E. Bowe | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.74 per share. | 10 Feb 2025 | 24,875 | 118,641 (0%) | 0% | 40.7 | 1,013,408 | Common Stock |
| Constellation Energy | James McHugh | EVP & Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 321.83 per share. | 10 Feb 2025 | 24,817 | 40,893 | - | 321.8 | 7,986,855 | Common Stock |
| Biodesix Inc | Robin Harper Cowie | CFO, Secy & Treasurer | Sale of securities on an exchange or to another person at price $ 0.92 per share. | 10 Feb 2025 | 24,664 | 246,460 | - | 0.9 | 22,794 | Common Stock |
| Alliance Resource Partners, LP - Unit | Thomas M. Wynne | SENIOR VICE PRESIDENT AND COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.28 per share. | 10 Feb 2025 | 24,507 | 890,034 (0%) | 0% | 27.3 | 668,551 | Common unit |
| Prudential Financial | Robert M. Falzon | EVP and Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 112.09 per share. | 10 Feb 2025 | 24,457 | 235,954 (0%) | 0% | 112.1 | 2,741,385 | Common Stock |
| Prudential Financial | Scott Case | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 24,456 | 24,456 | - | - | 2025 Performance Shares | |
| FVCBankcorp Inc | Patricia A. Ferrick | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.63 per share. | 10 Feb 2025 | 24,261 | 175,883 (1%) | 0% | 12.6 | 306,416 | Common Stock |
| Vertex Inc (Class A) | John R. Schwab | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 24,009 | 24,010 | - | - | Restricted Stock Units | |
| Vertex Inc (Class A) | John R. Schwab | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 24,009 | 77,113 | - | 0 | Class A Common Stock | |
| Disc Medicine Inc | Rahul Khara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 24,000 | 38,035 | - | 0 | Common Stock | |
| Disc Medicine Inc | Jonathan Yu | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 24,000 | 42,165 | - | 0 | Common Stock | |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 174.72 per share. | 10 Feb 2025 | 23,933 | 2,347,035 | - | 174.7 | 4,181,574 | Class A Common Stock |
| Constellation Energy | Daniel Eggers | EVP & CFO | Sale or transfer of securities back to the company at price $ 321.83 per share. | 10 Feb 2025 | 23,894 | 29,040 | - | 321.8 | 7,689,806 | Common Stock |
| A.O. Smith | Stephen M. Shafer | COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 23,815 | 64,240 | - | - | Restricted Stock Units | |
| Equifax | Mark W. Begor | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 23,519 | 23,519 | - | - | Stock Option/Right to Buy | |
| VeriSign | D. James Bidzos | Director, Exec. Chairman, Pres, & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 23,398 | 551,719 (0%) | 0% | 0 | Common Stock | |
| Manitowoc Co. Inc | Aaron H. Ravenscroft | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.91 per share. | 10 Feb 2025 | 23,218 | 491,707 (1%) | 0% | 9.9 | 230,090 | Common Stock |
| Insmed Inc | Martina Flammer | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 79.33 per share. | 10 Feb 2025 | 23,010 | 100,165 (0%) | 0% | 79.3 | 1,825,383 | Common Stock |
| Fastly Inc (Class A) | Artur Bergman | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 22,697 | 3,386,833 (4%) | 0% | 0 | Class A Common Stock | |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 176.57 per share. | 10 Feb 2025 | 22,544 | 2,453,738 | - | 176.6 | 3,980,594 | Class A Common Stock |
| Beazer Homes USA Inc | Lloyd E. Johnson | Director | Purchase of securities on an exchange or from another person at price $ 22.23 per share. | 10 Feb 2025 | 22,500 | 45,000 (0%) | 0% | 22.2 | 500,236 | Common Stock |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 172.28 per share. | 10 Feb 2025 | 22,377 | 2,248,995 | - | 172.3 | 3,855,110 | Class A Common Stock |
| Collegium pharma Inc | Colleen Tupper | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.52 per share. | 10 Feb 2025 | 22,317 | 179,144 (0%) | 0% | 30.5 | 681,115 | Common Stock |
| Bancorp Inc | Damian M. Kozlowski | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.92 per share. | 10 Feb 2025 | 22,218 | 657,656 (1%) | 0% | 61.9 | 1,375,663 | Common Stock |
| Andersons Inc | Patrick E. Bowe | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Feb 2025 | 22,198 | 18,910 | - | - | PERFORMANCE SHARE UNIT (TSR) (2025) | |
| Prudential Financial | Andrew F. Sullivan | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 22,168 | 37,291 (0%) | 0% | 0 | Common Stock | |
| Constellation Energy | James McHugh | EVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.83 per share. | 10 Feb 2025 | 22,012 | 65,710 | - | 321.8 | 7,084,122 | Common Stock |
| SiTime Corp | Rajesh Vashist | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 21,992 | 463,280 (3%) | 0% | 0 | Common Stock | |
| Warrior Met Coal Inc | Charles Lussier | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 21,978 | 80,771 (0%) | 0% | 0 | Common Stock | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | 10 Feb 2025 | 21,728 | 487,058 (0%) | 0% | 0.9 | 19,755 | Class A Common Stock | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | 10 Feb 2025 | 21,728 | 8,544,080 | - | - | Class B Common Stock | ||
| Collegium pharma Inc | Scott Dreyer | EVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.52 per share. | 10 Feb 2025 | 21,670 | 147,706 (0%) | 0% | 30.5 | 661,368 | Common Stock |
| Equifax | Mark W. Begor | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 21,668 | 21,668 | - | - | Stock Option/Right to Buy | |
| Dominari Holdings Inc | Ronald Craig Lieberman | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Feb 2025 | 21,613 | 21,613 | - | - | Series A Warrants (right to buy) | |
| Dominari Holdings Inc | Ronald Craig Lieberman | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Feb 2025 | 21,613 | 21,613 | - | - | Series B Warrants (right to buy) | |
| Dominari Holdings Inc | Ronald Craig Lieberman | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Feb 2025 | 21,613 | 21,613 (0%) | 0% | - | Common Stock | |
| United Airlines Holdings | Andrew P. Nocella | EVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.08 per share. | 10 Feb 2025 | 21,556 | 139,564 (0%) | 0% | 106.1 | 2,286,660 | Common Stock |
| Yum Brands | David W. Gibbs | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 148.15 per share. | 10 Feb 2025 | 21,417 | 187,184 (0%) | 0% | 148.2 | 3,172,929 | Common Stock |
| Prudential Financial | Yanela C. Frias | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 21,412 | 21,412 | - | - | 2025 Performance Shares | |
| United Airlines Holdings | Kate Gebo | EVP HR and Labor Relations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.08 per share. | 10 Feb 2025 | 21,368 | 69,965 (0%) | 0% | 106.1 | 2,266,717 | Common Stock |
| SiTime Corp | Rajesh Vashist | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 21,350 | 484,630 (3%) | 0% | 0 | Common Stock | |
| Prudential Financial | Ann M Kappler | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 21,144 | 21,144 | - | - | 2025 Performance Shares | |
| Gartner | Eugene A. Hall | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 20,938 | 1,178,594 (1%) | 0% | 0 | Common Stock | |
| Gartner | Eugene A. Hall | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 20,938 | 0 | - | - | Restricted Stock Units | |
| Alliance Resource Partners, LP - Unit | Timothy J. Whelan | SENIOR VICE PRESIDENT SALES | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.28 per share. | 10 Feb 2025 | 20,898 | 143,850 (0%) | 0% | 27.3 | 570,097 | Common unit |
| Cisco | Charles H. Robbins | Director, Chair and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.27 per share. | 10 Feb 2025 | 20,767 | 768,103 (0%) | 0% | 62.3 | 1,293,161 | Common Stock |
| Bancorp Inc | Gregor J. Garry | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 20,746 | 133,443 (0%) | 0% | - | Common Stock | |
| Ingersoll Rand | Andrew Schiesl | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 20,718 | 51,564 (0%) | 0% | 0 | Common Stock | |
| Crane Holdings Co. | Max H. Mitchell | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 20,369 | 20,369 | - | - | Employee Stock Option (Right to Buy) | |
| Manitowoc Co. Inc | Aaron H. Ravenscroft | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 20,338 | 514,925 (1%) | 0% | 0 | Common Stock | |
| Boston Properties Inc | Owen D. Thomas | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 20,076 | 820,768 | - | - | LTIP Units | |
| Southwest Airlines | Robert E. Jordan | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 20,069 | 486,888 (0%) | 0% | 0 | Common Stock | |
| Landmark Bancorp Inc | Patrick L. Alexander | Director | Sale of securities on an exchange or to another person at price $ 24.53 per share. | 10 Feb 2025 | 20,000 | 80,285 (1%) | 0% | 24.5 | 490,600 | Common Stock |
| PC Connection Inc | Thomas C. Baker | Sr. VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| PC Connection Inc | Patricia Gallup | Director, Chairman & Chief Admin Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| Helmerich & Payne Inc | John W. Lindsay | Director, PRESIDENT AND CEO | 10 Feb 2025 | 20,000 | 691,214 (0%) | 0% | 27.6 | 551,000 | Common Stock | |
| Meridian Holdings Inc | Aleksandar Milovanovic | Ten Percent Owner, Member of 10% Reporting Group | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 10 Feb 2025 | 20,000 | 78,014,616 | - | 1.9 | 37,000 | Common Stock |
| Intapp Inc | Thad Jampol | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 20,000 | 29,198 | - | - | Employee Stock Option (Right to Buy) | |
| Intapp Inc | Thad Jampol | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 10 Feb 2025 | 20,000 | 848,197 | - | 4.0 | 79,800 | Common Stock |
| Bancorp Inc | Olek DeRowe | EVP Head Commercial RE | 10 Feb 2025 | 19,917 | 93,080 (0%) | 0% | - | Common Stock | ||
| Devon Energy | Tana K. Cashion | EVP Human Resources and Admin | 10 Feb 2025 | 19,849 | 125,040 (0%) | 0% | 0 | Common Stock | ||
| Crane Holdings Co. | Max H. Mitchell | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 19,813 | 19,813 | - | - | 2025 Performance-Based RSU | |
| Alliance Resource Partners, LP - Unit | Mark Allen Watson | SrVP - Operations & Technology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 19,735 | 0 | - | - | Restricted unit | |
| Alliance Resource Partners, LP - Unit | Mark Allen Watson | SrVP - Operations & Technology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 19,735 | 44,735 (0%) | 0% | - | Common unit | |
| Allstate | Jesse E. Merten | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 124.26 per share. | 10 Feb 2025 | 19,672 | 38,487 (0%) | 0% | 124.3 | 2,444,443 | Common Stock |
| Allstate | Jesse E. Merten | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 19,672 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Constellation Energy | Kathleen Barron | EVP & Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.83 per share. | 10 Feb 2025 | 19,670 | 45,964 | - | 321.8 | 6,330,396 | Common Stock |
| Devon Energy | Richard E. Muncrief | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.26 per share. | 10 Feb 2025 | 19,558 | 1,995,597 (0%) | 0% | 34.3 | 670,057 | Common Stock |
| Roblox Corp (Class A) | Mark Reinstra | Chief Legal Off. & Corp. Sec. | Sale of securities on an exchange or to another person at price $ 65.94 per share. | 10 Feb 2025 | 19,525 | 339,206 | - | 65.9 | 1,287,557 | Class A Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 19,282 | 19,282 | - | - | Performance Share Units | |
| United Airlines Holdings | Torbjorn J. Enqvist | EVP & Chief Operations Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.08 per share. | 10 Feb 2025 | 19,280 | 62,468 (0%) | 0% | 106.1 | 2,045,222 | Common Stock |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 173.98 per share. | 10 Feb 2025 | 19,174 | 2,305,222 | - | 174.0 | 3,335,893 | Class A Common Stock |
| Onto Innovation Inc | Michael P. Plisinski | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 19,048 | 166,681 (0%) | 0% | 0 | Common Stock | |
| Constellation Energy | Michael R. Koehler | EVP & Chief Admin Officer | Sale or transfer of securities back to the company at price $ 321.83 per share. | 10 Feb 2025 | 18,921 | 39,017 | - | 321.8 | 6,089,345 | Common Stock |
| Andersons Inc | Patrick E. Bowe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 18,910 | 0 | - | - | PERFORMANCE SHARE UNIT (TSR) (2025) | |
| Andersons Inc | Patrick E. Bowe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 18,910 | 99,084 (0%) | 0% | 0 | Common Stock | |
| Eli Lilly | Daniel M. Skovronsky | EVP, CSO & Pres. LRL & LLY Imm | Grant, award, or other acquisition of securities at price $ 868.91 per share. | 10 Feb 2025 | 18,771 | 136,660 (0%) | 0% | 868.9 | 16,310,400 | Common Stock |
| Archer-Daniels-Midland | Jennifer L. Weber | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 18,685 | 128,593 (0%) | 0% | 0 | Common Stock | |
| Prudential Financial | Lucien Alziari | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 18,401 | 18,401 | - | - | 2025 Performance Shares | |
| Bancorp Inc | John Leto | EVP Head of Institutional Bank | 10 Feb 2025 | 18,257 | 173,027 (0%) | 0% | - | Common Stock | ||
| Bancorp Inc | Jeffrey A. Nager | EVP Head of Commercial Lending | 10 Feb 2025 | 18,257 | 130,784 (0%) | 0% | - | Common Stock | ||
| Yum China Holdings Inc | Warton Wang | General Manager, KFC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 18,203 | 18,203 | - | - | Restricted Stock Unit | |
| UNIFI Inc | Kenneth G. Langone | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.43 per share. | 10 Feb 2025 | 18,000 | 2,370,000 (12%) | 0% | 5.4 | 97,740 | Common Stock |
| Constellation Energy | Kathleen Barron | EVP & Chief Strategy Officer | Sale or transfer of securities back to the company at price $ 321.83 per share. | 10 Feb 2025 | 17,978 | 27,986 | - | 321.8 | 5,785,860 | Common Stock |
| Johnson Controls | George R. Oliver | Chairman & CEO | Sale of securities on an exchange or to another person at price $ 89.60 per share. | 10 Feb 2025 | 17,858 | 1,203,892 (0%) | 0% | 89.6 | 1,600,077 | Ordinary Shares |
| Warrior Met Coal Inc | Jack K. Richardson | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.39 per share. | 10 Feb 2025 | 17,845 | 185,432 (0%) | 0% | 53.4 | 952,745 | Common Stock |
| Lattice Semiconductor Corp | Lorenzo A. Flores | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 17,729 | 17,729 (0%) | 0% | 0 | Common Stock | |
| XPLR infra LP. - Unit | Peter H. Kind | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 17,630 | 56,760 (0%) | 0% | 0 | Common Units Representing Limited Partner Interests | |
| Constellation Energy | David Dardis | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.83 per share. | 10 Feb 2025 | 17,594 | 40,915 | - | 321.8 | 5,662,277 | Common Stock |
| Modine Manufacturing Co. | Michael Lucareli | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.26 per share. | 10 Feb 2025 | 17,541 | 150,072 (0%) | 0% | 13.3 | 232,594 | Common stock |
| Modine Manufacturing Co. | Michael Lucareli | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 17,541 | 11,996 | - | - | Employee stock option (Right to buy) | |
| Modine Manufacturing Co. | Michael Lucareli | EVP, CFO | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 10 Feb 2025 | 17,541 | 132,531 (0%) | 0% | 100 | 1,754,100 | Common stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.92 per share. | 10 Feb 2025 | 17,527 | 128,039 | - | 0.9 | 16,198 | Common Stock |
| Devon Energy | John D. Raines | SVP, E&P Asset Management | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 17,514 | 43,948 (0%) | 0% | 0 | Common Stock | |
| Devon Energy | Thomas J. Hellman | SVP, E&P Operations | 10 Feb 2025 | 17,514 | 17,514 (0%) | 0% | 0 | Common Stock | ||
| Janover Inc | Ned L. Siegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 17,500 | 17,500 | - | - | Stock Option (Right to buy) | |
| Allison Transmission Holdings Inc | G. Frederick Bohley | COO, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 17,316 | 17,316 | - | - | Performance Stock Units |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.